Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00LCT
|
|||
Former ID |
DIB005003
|
|||
Drug Name |
Symakalim
|
|||
Synonyms |
EMD-57283
Click to Show/Hide
|
|||
Indication | Hypertension [ICD-11: BA00-BA04; ICD-9: 401] | Discontinued in Phase 1 | [1] | |
Company |
Merck KGaA
|
|||
Structure |
Download2D MOL |
|||
Formula |
C17H17N3O4
|
|||
Canonical SMILES |
CC1(C(C(C2=C(O1)C=CC(=C2)C#N)OC3=NN(C(=O)C=C3)C)O)C
|
|||
InChI |
1S/C17H17N3O4/c1-17(2)16(22)15(23-13-6-7-14(21)20(3)19-13)11-8-10(9-18)4-5-12(11)24-17/h4-8,15-16,22H,1-3H3
|
|||
InChIKey |
RIBYSHCVSQIIJE-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Potassium channel unspecific (KC) | Target Info | Agonist | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003464) | |||
REF 2 | Synthesis and antihypertensive activity of 4-(diazabicyclo[4.1.0]-heptenyloxy)benzopyran derivatives and their analogues. Chem Pharm Bull (Tokyo). 1998 Apr;46(4):602-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.